These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9442549)

  • 1. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
    Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
    Pharmacopsychiatry; 1997 Nov; 30(6):263-5. PubMed ID: 9442549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First report of mirtazapine overdose.
    Hoes MJ; Zeijpveld JH
    Int Clin Psychopharmacol; 1996 Jun; 11(2):147. PubMed ID: 8803652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of drug-induced psychosis in Parkinson's disease with clozapine.
    Greene P; Cote L; Fahn S
    Adv Neurol; 1993; 60():703-6. PubMed ID: 8420214
    [No Abstract]   [Full Text] [Related]  

  • 5. Clozapine prevents recurrence of psychosis in Parkinson's disease.
    Factor SA; Brown D
    Mov Disord; 1992; 7(2):125-31. PubMed ID: 1350059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Levodopa dependency in Parkinson's disease: case report and review].
    Müller U; Reuter M; Hermann W; Gertz HJ
    Nervenarzt; 2002 Sep; 73(9):887-91. PubMed ID: 12215883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Meco G; Bernardi S
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mirtazapine-induced worsening of restless legs syndrome (RLS) and ropinirole-induced psychosis: challenges in management of depression in RLS.
    Chopra A; Pendergrass DS; Bostwick JM
    Psychosomatics; 2011; 52(1):92-4. PubMed ID: 21300203
    [No Abstract]   [Full Text] [Related]  

  • 9. [Levodopa-induced psychosis in patients with idiopathic Parkinson disease].
    García-Escrig M; Bermejo Pareja F; Fernández Ponsatí JT
    Med Clin (Barc); 1999 Feb; 112(7):245-50. PubMed ID: 10220750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zotepine in levodopa-induced Psychosis.
    Spieker S; Stetter F; Klockgether T
    Mov Disord; 1995 Nov; 10(6):795-7. PubMed ID: 8750001
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of serotonin in clinical features of Parkinson's disease and complications of L-DOPA therapy.
    Melamed E; Zoldan J; Friedberg G; Ziv I; Weizmann A
    Adv Neurol; 1996; 69():545-50. PubMed ID: 8615179
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.
    Hamadjida A; Nuara SG; Veyres N; Frouni I; Kwan C; Sid-Otmane L; Harraka MJ; Gourdon JC; Huot P
    Psychopharmacology (Berl); 2017 Mar; 234(6):905-911. PubMed ID: 28130646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S; Factor SA; Molho ES; Feustel PJ
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does domperidone potentiate mirtazapine-associated restless legs syndrome?
    Chang CC; Shiah IS; Chang HA; Mao WC
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):316-8. PubMed ID: 16309808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Montastruc JL; Schmitt L; Bagheri H
    Rev Neurol (Paris); 2003 Apr; 159(4):441-3. PubMed ID: 12773874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of mirtazapine in clinically relevant subgroups of depressed patients.
    Nutt DJ
    Depress Anxiety; 1998; 7 Suppl 1():7-10. PubMed ID: 9597345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dopaminomimetic psychosis in Parkinson's disease: first symptom of early dementia?].
    Catalan-Alonso MJ; Del Val J
    Rev Neurol; 2001 Jun 1-15; 32(11):1085-7. PubMed ID: 11562835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirtazapine: a newer antidepressant.
    Hartmann PM
    Am Fam Physician; 1999 Jan; 59(1):159-61. PubMed ID: 9917581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mirtazapine: an antidepressant with noradrenergic and specific serotonergic effects.
    Stimmel GL; Dopheide JA; Stahl SM
    Pharmacotherapy; 1997; 17(1):10-21. PubMed ID: 9017762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.